-
-
Study finds M-CHAT autism screening misses 38% of high-risk toddlers
-
Designing proteins by their motion, not just their shape
Understanding protein motion could greatly aid new drug design
Novartis Keeps Deals Coming With $2B Excellergy Takeover
Rocket’s Gene Therapy Wins FDA Greenlight, Clearing Way for Future Products
In The News
- Implantable islet cells could control diabetes without insulin injections March 27, 2026 By News Team
- DNA shape explains crucial gene-therapy challenges March 27, 2026 By News Team
- Beam’s Base Editor Advances to Pivotal Development on Back of ‘Impressive’ AATD Data March 27, 2026 By News Team
- Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune February 10, 2026 By News Team
- Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill February 07, 2026 By News Team
Biotechnology Daily
more-
Designing proteins by their motion, not just their shape
Proteins are far more than nutrients we track on a food label. Present in every…
Market Watch
more-
Orphan Drug Status Creates Unprecedented Investment Returns Worth Billions
The pharmaceutical industry has discovered a goldmine hiding in plain sight. While major drug companies…
Record Investments Pour Into Gene Therapy Companies as Clinical Breakthroughs Reshape Treatment Paradigms
Smart Investors Are Tracking These Explosive Biotech Short Squeeze Opportunities
Market Forces Reshape the Global Biosimilar Competition Landscape
Why Orphan Drug Status Has Become Biotech’s Most Valuable Regulatory Pathway
Bio Business News
moreNovartis Keeps Deals Coming With $2B Excellergy Takeover
The Excellergy acquisition will complement Novartis’ existing allergy profile, anchored…
Rocket’s Gene Therapy Wins FDA Greenlight, Clearing Way for Future Products
While the accelerated approval unlocks only a small market opportunity…
Wave Stock Cut in Half on Underwhelming Higher Dose Obesity Data
While participants on a lower dose of Wave Life Sciences’…
World News
moreGut ‘primes’ pathogenic T cells responsible for neuroinflammation in multiple sclerosis, study finds
Multiple sclerosis (MS) is a debilitating neurological disorder caused by…
Study finds M-CHAT autism screening misses 38% of high-risk toddlers
M-CHAT does not catch all children with autism in the…
Small RNAs offer new clues to schizophrenia and bipolar disorder
For decades, scientists studying brain disorders have focused almost exclusively…
Gut ‘primes’ pathogenic T cells responsible for neuroinflammation in multiple sclerosis, study finds
Study finds M-CHAT autism screening misses 38% of high-risk toddlers
Designing proteins by their motion, not just their shape
Understanding protein motion could greatly aid new drug design
Novartis Keeps Deals Coming With $2B Excellergy Takeover
Rocket’s Gene Therapy Wins FDA Greenlight, Clearing Way for Future Products
Orphan Drug Status Creates Unprecedented Investment Returns Worth Billions
IND Filing Milestones Transform Drug Development Landscape for Patients and Markets
Small RNAs offer new clues to schizophrenia and bipolar disorder
Implantable islet cells could control diabetes without insulin injections